Kurs
-2,14%
Likviditet
0,60 MEUR
Prenumeration
Kalender
Tid* | ||
2025-10-30 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-07 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-04-29 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-04-10 | N/A | Årsstämma |
2025-02-13 | 08:00 | Bokslutskommuniké 2024 |
2024-10-31 | - | Kvartalsrapport 2024-Q3 |
2024-08-08 | - | Kvartalsrapport 2024-Q2 |
2024-04-25 | - | Kvartalsrapport 2024-Q1 |
2024-04-05 | - | X-dag ordinarie utdelning REG1V 0.38 EUR |
2024-04-04 | - | Årsstämma |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-08-10 | - | Kvartalsrapport 2023-Q2 |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-03-24 | - | X-dag ordinarie utdelning REG1V 0.36 EUR |
2023-03-23 | - | Årsstämma |
2023-02-09 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-08-04 | - | Kvartalsrapport 2022-Q2 |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-04-11 | - | X-dag ordinarie utdelning REG1V 0.34 EUR |
2022-04-08 | - | Årsstämma |
2022-02-10 | - | Bokslutskommuniké 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-08-05 | - | Kvartalsrapport 2021-Q2 |
2021-04-23 | - | Kvartalsrapport 2021-Q1 |
2021-03-18 | - | X-dag ordinarie utdelning REG1V 0.32 EUR |
2021-03-17 | - | Årsstämma |
2021-02-11 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-08-06 | - | Kvartalsrapport 2020-Q2 |
2020-06-09 | - | X-dag ordinarie utdelning REG1V 0.30 EUR |
2020-06-08 | - | Årsstämma |
2020-04-22 | - | Kvartalsrapport 2020-Q1 |
2020-02-20 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-04-16 | - | Kvartalsrapport 2019-Q1 |
2019-03-21 | - | X-dag ordinarie utdelning REG1V 0.28 EUR |
2019-03-20 | - | Årsstämma |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-08-06 | - | Kvartalsrapport 2018-Q2 |
2018-04-20 | - | Kvartalsrapport 2018-Q1 |
2018-03-21 | - | X-dag ordinarie utdelning REG1V 0.78 EUR |
2018-03-20 | - | Årsstämma |
2018-02-15 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-08-07 | - | Kvartalsrapport 2017-Q2 |
2017-05-22 | - | Årsstämma |
2017-04-20 | - | Kvartalsrapport 2017-Q1 |
2017-03-23 | - | X-dag ordinarie utdelning REG1V 0.74 EUR |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-10-31 | - | Kvartalsrapport 2016-Q3 |
2016-08-08 | - | Kvartalsrapport 2016-Q2 |
2016-04-25 | - | Kvartalsrapport 2016-Q1 |
2016-03-16 | - | X-dag ordinarie utdelning REG1V 0.70 EUR |
2016-03-15 | - | Årsstämma |
2016-02-15 | - | Bokslutskommuniké 2015 |
2015-10-27 | - | Kvartalsrapport 2015-Q3 |
2015-08-10 | - | Kvartalsrapport 2015-Q2 |
2015-04-24 | - | Kvartalsrapport 2015-Q1 |
2015-03-20 | - | X-dag ordinarie utdelning REG1V 0.45 EUR |
2015-03-19 | - | Årsstämma |
2015-02-12 | - | Bokslutskommuniké 2014 |
2014-10-21 | - | Kvartalsrapport 2014-Q3 |
2014-08-04 | - | Kvartalsrapport 2014-Q2 |
2014-04-24 | - | Kvartalsrapport 2014-Q1 |
2014-03-21 | - | X-dag ordinarie utdelning REG1V 0.30 EUR |
2014-03-20 | - | Årsstämma |
2014-02-12 | - | Bokslutskommuniké 2013 |
2013-12-11 | - | X-dag bonusutdelning REG1V 0.3 |
2013-12-09 | - | Extra Bolagsstämma 2013 |
2013-10-22 | - | Kvartalsrapport 2013-Q3 |
2013-08-28 | - | Kapitalmarknadsdag 2013 |
2013-08-05 | - | Kvartalsrapport 2013-Q2 |
2013-08-02 | - | X-dag bonusutdelning REG1V 0.12 |
2013-04-19 | - | Kvartalsrapport 2013-Q1 |
2013-03-28 | - | Split REG1V 10:1 |
2013-03-22 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
2013-03-21 | - | Årsstämma |
2013-02-08 | - | Bokslutskommuniké 2012 |
2012-10-19 | - | Kvartalsrapport 2012-Q3 |
2012-08-06 | - | Kvartalsrapport 2012-Q2 |
2012-04-19 | - | Kvartalsrapport 2012-Q1 |
2012-03-29 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
2012-03-28 | - | Årsstämma |
2012-02-16 | - | Bokslutskommuniké 2011 |
2011-10-26 | - | Kvartalsrapport 2011-Q3 |
2011-08-08 | - | Kvartalsrapport 2011-Q2 |
2011-04-27 | - | Kvartalsrapport 2011-Q1 |
2011-04-01 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
2011-03-31 | - | Årsstämma |
2011-02-16 | - | Bokslutskommuniké 2010 |
2010-04-09 | - | X-dag ordinarie utdelning REG1V 0.01 EUR |
2009-04-16 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
2008-04-03 | - | X-dag ordinarie utdelning REG1V 0.04 EUR |
2007-04-09 | - | X-dag ordinarie utdelning REG1V 0.01 EUR |
2006-03-31 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
2005-04-01 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
2004-03-29 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
2003-03-24 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
2002-04-15 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
Beskrivning
Land | Finland |
---|---|
Lista | Large Cap Helsinki |
Sektor | Hälsovård |
Industri | Medicinteknik |
Revenio Group Corporation, Press release, January 25, 2023 at 2.00 p.m. (EET)
Invitation to Revenio Group Corporation’s audiocast and teleconference call
Revenio Group Corporation’s Financial Statement Release 2022 will be published on Thursday, February 9, 2023, approximately at 09.00 a.m. (EET). The report will be available at https://www.reveniogroup.fi/en/investors/reports_and_presentations.
An audiocast and teleconference call for analysts and investors will be held in English at 3.00 p.m. (EET) on the same day.
Audiocast: https://revenio.videosync.fi/2022-q4-result
To ask questions, please join the teleconference by registering using the following link: http://palvelu.flik.fi/teleconference/?id=10010580
After the registration, you will be provided with phone numbers and a conference ID to access the conference. To ask a question, please press *5 on your telephone keypad to enter the queue.
A recording of the audiocast will be published on https://www.reveniogroup.fi/en/ after the event.
For further information, please contact
Robin Pulkkinen, CFO, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
Distribution
Key media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.